Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017

Haiti is striving for zero local malaria transmission by the year 2025. Chloroquine remains the first-line treatment, and sulfadoxine/pyrimethamine (SP) has been used for mass drug-administration pilot programs. In March 2016, nationwide molecular surveillance was initiated to assess molecular resis...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Eric Rogier, Camelia Herman, Curtis S. Huber, Karen E.S. Hamre, Baby Pierre, Kimberly E. Mace, Jacquelin Présumé, Gina Mondélus, Ithamare Romilus, Tamara Elismé, Thomas P. Eisele, Thomas Druetz, Alexandre Existe, Jacques Boncy, Jean F. Lemoine, Venkatachalam Udhayakumar, Michelle A. Chang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Centers for Disease Control and Prevention 2020-05-01
Serie:Emerging Infectious Diseases
Soggetti:
Plasmodium falciparum
Haiti
drug resistance
chloroquine
sulfadoxine
pyrimethamine
Accesso online:https://wwwnc.cdc.gov/eid/article/26/5/19-0556_article
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi